These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 2885269)
1. Conversion of B1 kinin receptor-mediated vascular relaxation to contraction. Churchill L; Ward PE Hypertension; 1987 Jun; 9(6 Pt 2):III1-5. PubMed ID: 2885269 [TBL] [Abstract][Full Text] [Related]
2. Relaxation of isolated mesenteric arteries by des-Arg9-bradykinin stimulation of B1 receptors. Churchill L; Ward PE Eur J Pharmacol; 1986 Oct; 130(1-2):11-8. PubMed ID: 2877891 [TBL] [Abstract][Full Text] [Related]
3. B1 and B2 kinin receptors on cultured rabbit superior mesenteric artery smooth muscle cells: receptor-specific stimulation of inositol phosphate formation and arachidonic acid release by des-Arg9-bradykinin and bradykinin. Tropea MM; Gummelt D; Herzig MS; Leeb-Lundberg LM J Pharmacol Exp Ther; 1993 Feb; 264(2):930-7. PubMed ID: 8382284 [TBL] [Abstract][Full Text] [Related]
4. The role of B1 and B2 kinin receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG). Campos MM; Henriques MG; Calixto JB Br J Pharmacol; 1997 Feb; 120(3):502-8. PubMed ID: 9031756 [TBL] [Abstract][Full Text] [Related]
5. Bradykinin B1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis. Butt SK; Dawson LG; Hall JM Br J Pharmacol; 1995 Feb; 114(3):612-7. PubMed ID: 7735687 [TBL] [Abstract][Full Text] [Related]
6. Systemic treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG) potentiates kinin B1 receptor agonist-induced nociception and oedema formation in the formalin test in mice. de Campos RO; Henriques MG; Calixto JB Neuropeptides; 1998 Oct; 32(5):393-403. PubMed ID: 9844998 [TBL] [Abstract][Full Text] [Related]
7. Vascular mode of action of kinin B1 receptors and development of a cellular model for the investigation of these receptors. Levesque L; Drapeau G; Grose JH; Rioux F; Marceau F Br J Pharmacol; 1993 Aug; 109(4):1254-62. PubMed ID: 8104648 [TBL] [Abstract][Full Text] [Related]
8. Involvement of bradykinin B1 and B2 receptors in relaxation of mouse isolated trachea. Li L; Vaali K; Paakkari I; Vapaatalo H Br J Pharmacol; 1998 Apr; 123(7):1337-42. PubMed ID: 9579728 [TBL] [Abstract][Full Text] [Related]
9. Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins. Drapeau G; deBlois D; Marceau F J Pharmacol Exp Ther; 1991 Dec; 259(3):997-1003. PubMed ID: 1662280 [TBL] [Abstract][Full Text] [Related]
10. Characterization of bradykinin receptors in peripheral organs. Rhaleb NE; Rouissi N; Drapeau G; Jukic D; Regoli D Can J Physiol Pharmacol; 1991 Jul; 69(7):938-43. PubMed ID: 1720068 [TBL] [Abstract][Full Text] [Related]
11. The kinin B1 receptor antagonist des-Arg9-[Leu8]bradykinin: an antagonist of the angiotensin AT1 receptor which also binds to the AT2 receptor. Pruneau D; Duvoid A; Luccarini JM; Bélichard P; Bonnafous JC Br J Pharmacol; 1995 Jan; 114(1):115-8. PubMed ID: 7712006 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological and molecular evidence for kinin B1 receptor expression in urinary bladder of cyclophosphamide-treated rats. Belichard P; Luccarini JM; Defrêne E; Faye P; Franck RM; Duclos H; Paquet JL; Pruneau D Br J Pharmacol; 1999 Sep; 128(1):213-9. PubMed ID: 10498854 [TBL] [Abstract][Full Text] [Related]
14. Action and metabolism of des(Arg)kinins in mesenteric arteries. Churchill L; McGiff JC; Ward PE Adv Exp Med Biol; 1986; 198 Pt A():571-5. PubMed ID: 3812095 [TBL] [Abstract][Full Text] [Related]
15. The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors. Meini S; Lecci A; Maggi CA Br J Pharmacol; 1996 Apr; 117(8):1619-24. PubMed ID: 8732268 [TBL] [Abstract][Full Text] [Related]
16. Up-regulation of [3H]-des-Arg10-kallidin binding to the bradykinin B1 receptor by interleukin-1 beta in isolated smooth muscle cells: correlation with B1 agonist-induced PGI2 production. Galizzi JP; Bodinier MC; Chapelain B; Ly SM; Coussy L; Giraud S; Neliat G; Jean T Br J Pharmacol; 1994 Oct; 113(2):389-94. PubMed ID: 7834189 [TBL] [Abstract][Full Text] [Related]
17. Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins. Drapeau G; Audet R; Levesque L; Godin D; Marceau F J Pharmacol Exp Ther; 1993 Jul; 266(1):192-9. PubMed ID: 8392550 [TBL] [Abstract][Full Text] [Related]
18. Bradykinin-induced vascular responses in dog isolated lingual artery. Tsukada M; Chiba S Clin Exp Pharmacol Physiol; 1999; 26(5-6):456-60. PubMed ID: 10386238 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy. Vianna RM; Calixto JB Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617 [TBL] [Abstract][Full Text] [Related]
20. Partial agonists and full antagonists at the human and murine bradykinin B1 receptors. MacNeil T; Feighner S; Hreniuk DL; Hess JF; Van der Ploeg LH Can J Physiol Pharmacol; 1997 Jun; 75(6):735-40. PubMed ID: 9276157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]